Diffuse Large B-Cell Lymphoma (DLBCL) Latest Advances

Efficacy and safety analysis of the salvage treatment for diffuse large B-cell lymphoma after the failure of anti-CD19 CAR-T therapy

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

The efficacy and safety of glofitamab combined with polatuzumab vedotin in the treatment of 9 cases of relapsed/refractory diffuse large B-cell lymphoma after failing CAR-T cell therapy

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Concordance of PD-1 expression on paired peripheral and bone marrow T cells: Surrogate potential and clinical implications in DLBCL.

Journal: The International journal of biological markers

Published: August 31, 2026

A case of diffuse large B-cell lymphoma achieving complete remission with epcoritamab after pseudoprogression.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: August 30, 2026

Diffuse large B-cell lymphoma of the axilla clinically mimicking hidradenitis suppurativa.

Journal: Wounds : a compendium of clinical research and practice

Published: August 25, 2026

Primary Colonic Diffuse Large B-cell Lymphoma: A Diagnostic Challenge.

Journal: Cureus

Published: August 24, 2026

Correction to: Prognostic factors and nomogram development for adult diffuse large B-cell lymphoma: a single-center retrospective cohort study.

Journal: BMC cancer

Published: August 23, 2026

Multifocal Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting on Face and Chest: Complete Remission With R-CHOP.

Journal: The American Journal of dermatopathology

Published: August 21, 2026

Extranodal diffuse large B-cell lymphoma presenting as a rapidly growing palatal mass in a patient with prior breast carcinoma.

Journal: BMJ case reports

Published: August 17, 2026

Palliative care and hospice utilization in patients with relapsed or refractory diffuse large B-cell lymphoma in the era of CART and novel immunotherapies.

Journal: Leukemia & lymphoma

Published: August 16, 2026

A RARE PRESENTATION OF DIFFUSE LARGE B-CELL LYMPHOMA AS SEVERE ACUTE HEPATITIS AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A YOUNG ADULT: A CASE REPORT.

Journal: Georgian medical news

Published: August 14, 2026

Retraction: Machine learning and validation reveal that immune-related genes in systemic lupus erythematosus regulate apoptosis and cycle progression in diffuse large B-cell lymphoma.

Journal: Frontiers in medicine

Published: August 13, 2026

Diffuse Large B-Cell Lymphoma (DLBCL) Latest Advances

Find the Latest Research About Diffuse Large B-Cell Lymphoma (DLBCL)

Efficacy and safety analysis of the salvage treatment for diffuse large B-cell lymphoma after the failure of anti-CD19 CAR-T therapy

Efficacy and safety analysis of the salvage treatment for diffuse large B-cell lymphoma after the failure of anti-CD19 CAR-T therapy

The efficacy and safety of glofitamab combined with polatuzumab vedotin in the treatment of 9 cases of relapsed/refractory diffuse large B-cell lymphoma after failing CAR-T cell therapy

The efficacy and safety of glofitamab combined with polatuzumab vedotin in the treatment of 9 cases of relapsed/refractory diffuse large B-cell lymphoma after failing CAR-T cell therapy

Concordance of PD-1 expression on paired peripheral and bone marrow T cells: Surrogate potential and clinical implications in DLBCL.

Concordance of PD-1 expression on paired peripheral and bone marrow T cells: Surrogate potential and clinical implications in DLBCL.

A case of diffuse large B-cell lymphoma achieving complete remission with epcoritamab after pseudoprogression.

A case of diffuse large B-cell lymphoma achieving complete remission with epcoritamab after pseudoprogression.

Diffuse large B-cell lymphoma of the axilla clinically mimicking hidradenitis suppurativa.

Diffuse large B-cell lymphoma of the axilla clinically mimicking hidradenitis suppurativa.

Primary Colonic Diffuse Large B-cell Lymphoma: A Diagnostic Challenge.

Primary Colonic Diffuse Large B-cell Lymphoma: A Diagnostic Challenge.

Correction to: Prognostic factors and nomogram development for adult diffuse large B-cell lymphoma: a single-center retrospective cohort study.

Correction to: Prognostic factors and nomogram development for adult diffuse large B-cell lymphoma: a single-center retrospective cohort study.

Multifocal Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting on Face and Chest: Complete Remission With R-CHOP.

Multifocal Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting on Face and Chest: Complete Remission With R-CHOP.

Extranodal diffuse large B-cell lymphoma presenting as a rapidly growing palatal mass in a patient with prior breast carcinoma.

Extranodal diffuse large B-cell lymphoma presenting as a rapidly growing palatal mass in a patient with prior breast carcinoma.

Palliative care and hospice utilization in patients with relapsed or refractory diffuse large B-cell lymphoma in the era of CART and novel immunotherapies.

Palliative care and hospice utilization in patients with relapsed or refractory diffuse large B-cell lymphoma in the era of CART and novel immunotherapies.

A RARE PRESENTATION OF DIFFUSE LARGE B-CELL LYMPHOMA AS SEVERE ACUTE HEPATITIS AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A YOUNG ADULT: A CASE REPORT.

A RARE PRESENTATION OF DIFFUSE LARGE B-CELL LYMPHOMA AS SEVERE ACUTE HEPATITIS AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A YOUNG ADULT: A CASE REPORT.

Retraction: Machine learning and validation reveal that immune-related genes in systemic lupus erythematosus regulate apoptosis and cycle progression in diffuse large B-cell lymphoma.

Retraction: Machine learning and validation reveal that immune-related genes in systemic lupus erythematosus regulate apoptosis and cycle progression in diffuse large B-cell lymphoma.